Submitted by Anonymous (not verified) on 19 September 2025 - 15:00
Human medicines European public assessment report (EPAR): Ordspono, odronextamab, Date of authorisation: 22/08/2024, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ordspono, odronextamab, Date of authorisation: 22/08/2024, Revision: 1, Status: Authorised